biologic

Pulmotech MAA

kit for the preparation of technetium Tc-99m albumin aggregated

Loss of exclusivityMarch 2032projected — 12-year biologic exclusivity estimate
CompanyCis Bio International

Drug detail

Brand namePulmotech MAA
Active ingredientkit for the preparation of technetium Tc-99m albumin aggregated
Strength2MG
Dosage formFor Injectable Suspension
RouteIntravenous, Intraperitoneal
ModalityBiologic
FDA approvalMarch 2020
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Pulmotech MAA patent cliff — loss of exclusivity March 2032 | CliffBio